Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease

the VICTORY Collaboration

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences